Antimicrobial synergism in the therapy of experimental cerebral nocardiosis

J Antimicrob Chemother. 1989 Jul;24(1):39-43. doi: 10.1093/jac/24.1.39.

Abstract

A mouse model of cerebral nocardiosis was used to determine the efficacy of synergistic antimicrobial combinations in reducing bacterial colony counts per gram of brain tissue. The combinations of imipenem-cefotaxime and imipenem-trimethoprim/sulphamethoxazole (TMP/SMP) were compared with each other and with each agent used alone. A saline treated control group was also included. At the completion of 72 h of therapy the combinations of imipenem-cefotaxime and imipenem-TMP/SMX were the most effective in reducing bacterial colony counts. These were statistically superior to cefotaxime and TMP/SMX used alone but not statistically superior to imipenem alone. TMP/SMX was not effective in this model and was inferior to all other antibiotic treatments.

MeSH terms

  • Animals
  • Brain Diseases / drug therapy*
  • Brain Diseases / microbiology
  • Cefotaxime / therapeutic use
  • Colony Count, Microbial
  • Drug Combinations / therapeutic use
  • Drug Synergism
  • Drug Therapy, Combination / therapeutic use*
  • Female
  • Imipenem / therapeutic use
  • Mice
  • Microbial Sensitivity Tests
  • Nocardia Infections / drug therapy*
  • Nocardia Infections / microbiology
  • Nocardia asteroides / drug effects
  • Sulfamethoxazole / therapeutic use
  • Trimethoprim / therapeutic use
  • Trimethoprim, Sulfamethoxazole Drug Combination

Substances

  • Drug Combinations
  • Imipenem
  • Trimethoprim, Sulfamethoxazole Drug Combination
  • Trimethoprim
  • Sulfamethoxazole
  • Cefotaxime